Irinotecan Hydrochloride Liposome - National Cancer Institute

Irinotecan Hydrochloride Liposome - National Cancer Institute

CANCER TREATMENT

• Types of Treatment
• Side Effects
• Clinical Trials Information for Patients and Caregivers
• A to Z List of Cancer Drugs
  • Drugs Approved for Different Types of Cancer
  • Drugs Approved for Conditions Related to Cancer
  • Off-Label Drug Use in Cancer Treatment
• Complementary & Alternative Medicine (CAM)
• Questions to Ask about Your Treatment
• Research

Irinotecan Hydrochloride Liposome

• 
• 
• 
• 
• 
• 
• 

(I-rih-noh-TEE-kan HY-droh-KLOR-ide LY-poh-some)

This page contains brief information about irinotecan hydrochloride liposome and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)

Onivyde

FDA Approved

Yes

FDA Approval for Irinotecan Hydrochloride Liposome

Use in Cancer

Irinotecan hydrochloride liposome is approved to be used with fluorouracil andleucovorin to treat:

• Pancreatic cancer that has metastasized (spread to other parts of the body). It is used in patients whose disease has gotten worse after treatment withgemcitabine.

Irinotecan hydrochloride liposome is also being studied in the treatment of other types of cancer.

Irinotecan hydrochloride liposome is a form of irinotecan hydrochloride contained inside liposomes (very tiny particles of fat). This form may work better than other forms of irinotecan hydrochloride and have fewer side effects. Also, because its effects last longer in the body, it doesn't need to be given as often. For more information about irinotecan hydrochloride that may apply to irinotecan hydrochloride liposome, see the Drug Information Summary for Irinotecan Hydrochloride.

More About Irinotecan Hydrochloride Liposome

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Clinical Trials Accepting Patients

Find Clinical Trials for Irinotecan Hydrochloride Liposome - Check for trials from NCI's list of cancer clinical trials now accepting patients.

Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.